559 related articles for article (PubMed ID: 28201949)
1. Evaluating efficacy of current lung cancer screening guidelines.
Nemesure B; Plank A; Reagan L; Albano D; Reiter M; Bilfinger TV
J Med Screen; 2017 Dec; 24(4):208-213. PubMed ID: 28201949
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer screening.
Tanoue LT; Tanner NT; Gould MK; Silvestri GA
Am J Respir Crit Care Med; 2015 Jan; 191(1):19-33. PubMed ID: 25369325
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Lung Cancer Screening Eligibility Using Simplified Criteria.
Triplette M; Donovan LM; Crothers K; Madtes DK; Au DH
Ann Am Thorac Soc; 2019 Oct; 16(10):1280-1285. PubMed ID: 31298946
[No Abstract] [Full Text] [Related]
4. Proportion of Non-Small-Cell Lung Cancer Patients that Would Have Been Eligible for Lung Cancer Screening.
Wu GX; Goldstein L; Kim JY; Raz DJ
Clin Lung Cancer; 2016 Sep; 17(5):e131-e139. PubMed ID: 26872765
[TBL] [Abstract][Full Text] [Related]
5. Lung Cancer Screening.
Hoffman RM; Sanchez R
Med Clin North Am; 2017 Jul; 101(4):769-785. PubMed ID: 28577626
[TBL] [Abstract][Full Text] [Related]
6. The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program.
Fintelmann FJ; Bernheim A; Digumarthy SR; Lennes IT; Kalra MK; Gilman MD; Sharma A; Flores EJ; Muse VV; Shepard JA
Radiographics; 2015; 35(7):1893-908. PubMed ID: 26495797
[TBL] [Abstract][Full Text] [Related]
7. Low-dose computed tomography screening for lung cancer: how strong is the evidence?
Woolf SH; Harris RP; Campos-Outcalt D
JAMA Intern Med; 2014 Dec; 174(12):2019-22. PubMed ID: 25317533
[TBL] [Abstract][Full Text] [Related]
8. Lung Cancer Screening: Computed Tomography Radiation and Protocols.
Murugan VA; Kalra MK; Rehani M; Digumarthy SR
J Thorac Imaging; 2015 Sep; 30(5):283-9. PubMed ID: 25856411
[TBL] [Abstract][Full Text] [Related]
9. Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening.
Howard DH; Richards TB; Bach PB; Kegler MC; Berg CJ
Cancer; 2015 Dec; 121(24):4341-7. PubMed ID: 26372542
[TBL] [Abstract][Full Text] [Related]
10. The United States Preventive Services Task Force recommendations for lung cancer screening.
Blackmon SH; Feinglass SR
Thorac Surg Clin; 2015 May; 25(2):199-203. PubMed ID: 25901563
[TBL] [Abstract][Full Text] [Related]
11. Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium.
Rendle KA; Burnett-Hartman AN; Neslund-Dudas C; Greenlee RT; Honda S; Elston Lafata J; Marcus PM; Cooley ME; Vachani A; Meza R; Oshiro C; Simoff MJ; Schnall MD; Beaber EF; Doria-Rose VP; Doubeni CA; Ritzwoller DP
Cancer Prev Res (Phila); 2020 Feb; 13(2):129-136. PubMed ID: 31871221
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
[TBL] [Abstract][Full Text] [Related]
13. Translating New Lung Cancer Screening Guidelines into Practice: The Experience of One Community Hospital.
Ledford CJ; Gawrys BL; Wall JL; Saas PD; Seehusen DA
J Am Board Fam Med; 2016; 29(1):152-5. PubMed ID: 26769888
[TBL] [Abstract][Full Text] [Related]
14. Lung Cancer Screening Update.
Ruchalski KL; Brown K
J Thorac Imaging; 2016 Jul; 31(4):190-200. PubMed ID: 27306387
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
[TBL] [Abstract][Full Text] [Related]
16. Performance of Risk Factor-Based Guidelines and Model-Based Chest CT Lung Cancer Screening in World Trade Center-Exposed Fire Department Rescue/Recovery Workers.
Cleven KL; Vaeth B; Zeig-Owens R; Colbeth HL; Jaber N; Schwartz T; Weiden MD; Markowitz SB; Silvestri GA; Prezant DJ
Chest; 2021 May; 159(5):2060-2071. PubMed ID: 33279511
[TBL] [Abstract][Full Text] [Related]
17. Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities.
Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
J Thorac Oncol; 2020 Nov; 15(11):1738-1747. PubMed ID: 32822843
[TBL] [Abstract][Full Text] [Related]
18. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?
Pinsky PF; Berg CD
J Med Screen; 2012 Sep; 19(3):154-6. PubMed ID: 23060474
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Revised US Preventive Services Task Force Lung Cancer Screening Guideline Among Women and Racial/Ethnic Minority Populations.
Reese TJ; Schlechter CR; Potter LN; Kawamoto K; Del Fiol G; Lam CY; Wetter DW
JAMA Netw Open; 2021 Jan; 4(1):e2033769. PubMed ID: 33433600
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer risk by years since quitting in 30+ pack year smokers.
Pinsky PF; Zhu CS; Kramer BS
J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]